Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Metabolomic Profiling of the Immune Stimulatory Effect of Eicosenoids on PMA-Differentiated THP-1 Cells.

Alqarni AM, Dissanayake T, Nelson DJ, Parkinson JA, Dufton MJ, Ferro VA, Watson DG.

Vaccines (Basel). 2019 Oct 9;7(4). pii: E142. doi: 10.3390/vaccines7040142.

2.

Microfluidic manufacturing of different niosomes nanoparticles for curcumin encapsulation: Physical characteristics, encapsulation efficacy, and drug release.

Obeid MA, Khadra I, Albaloushi A, Mullin M, Alyamani H, Ferro VA.

Beilstein J Nanotechnol. 2019 Sep 5;10:1826-1832. doi: 10.3762/bjnano.10.177. eCollection 2019.

3.

Propolis Exerts an Anti-Inflammatory Effect on PMA-Differentiated THP-1 Cells via Inhibition of Purine Nucleoside Phosphorylase.

Alqarni AM, Niwasabutra K, Sahlan M, Fearnley H, Fearnley J, Ferro VA, Watson DG.

Metabolites. 2019 Apr 16;9(4). pii: E75. doi: 10.3390/metabo9040075.

4.

Exosomes: fighting cancer with cancer.

Alyamani H, Obeid MA, Tate RJ, Ferro VA.

Ther Deliv. 2019 Jan;10(1):37-61. doi: 10.4155/tde-2018-0051. Erratum in: Ther Deliv. 2019 Feb;10(2):133.

PMID:
30730823
5.

Hibiscus acid from Hibiscus sabdariffa (Malvaceae) has a vasorelaxant effect on the rat aorta.

Zheoat AM, Gray AI, Igoli JO, Ferro VA, Drummond RM.

Fitoterapia. 2019 Apr;134:5-13. doi: 10.1016/j.fitote.2019.01.012. Epub 2019 Jan 25.

PMID:
30690125
6.

Uncommon Presentation of Childhood Leukemia in Emergency Department: The Usefulness of an Early Multidisciplinary Approach.

Boccuzzi E, Ferro VA, Cinicola B, Schingo PM, Strocchio L, Raucci U.

Pediatr Emerg Care. 2018 Nov 19. doi: 10.1097/PEC.0000000000001694. [Epub ahead of print]

PMID:
30461671
7.

Rationalising drug delivery using nanoparticles: a combined simulation and immunology study of GnRH adsorbed to silica nanoparticles.

Connell DJ, Gebril A, Khan MAH, Patwardhan SV, Kubiak-Ossowska K, Ferro VA, Mulheran PA.

Sci Rep. 2018 Nov 20;8(1):17115. doi: 10.1038/s41598-018-35143-7.

8.

Effect of Melittin on Metabolomic Profile and Cytokine Production in PMA-Differentiated THP-1 Cells.

Alqarni AM, Ferro VA, Parkinson JA, Dufton MJ, Watson DG.

Vaccines (Basel). 2018 Oct 13;6(4). pii: E72. doi: 10.3390/vaccines6040072.

9.

Proof of concept studies for siRNA delivery by nonionic surfactant vesicles: in vitro and in vivo evaluation of protein knockdown.

Obeid MA, Dufès C, Somani S, Mullen AB, Tate RJ, Ferro VA.

J Liposome Res. 2019 Sep;29(3):229-238. doi: 10.1080/08982104.2018.1531424. Epub 2019 Jan 1.

PMID:
30296860
10.

Towards a characterisation of the wild legume bitter vetch (Lathyrus linifolius L. (Reichard) Bässler): heteromorphic seed germination, root nodule structure and N-fixing rhizobial symbionts.

Dello Jacovo E, Valentine TA, Maluk M, Toorop P, Lopez Del Egido L, Frachon N, Kenicer G, Park L, Goff M, Ferro VA, Bonomi C, James EK, Iannetta PPM.

Plant Biol (Stuttg). 2019 May;21(3):523-532. doi: 10.1111/plb.12902. Epub 2018 Sep 19.

PMID:
30120872
11.

Delivering natural products and biotherapeutics to improve drug efficacy.

Obeid MA, Al Qaraghuli MM, Alsaadi M, Alzahrani AR, Niwasabutra K, Ferro VA.

Ther Deliv. 2017 Nov;8(11):947-956. doi: 10.4155/tde-2017-0060.

12.

Crystal structures of hibiscus acid and hibiscus acid dimethyl ester isolated from Hibiscus sabdariffa (Malvaceae).

Zheoat AM, Gray AI, Igoli JO, Kennedy AR, Ferro VA.

Acta Crystallogr E Crystallogr Commun. 2017 Aug 21;73(Pt 9):1368-1371. doi: 10.1107/S2056989017011902. eCollection 2017 Sep 1.

13.

Formulation of Nonionic Surfactant Vesicles (NISV) Prepared by Microfluidics for Therapeutic Delivery of siRNA into Cancer Cells.

Obeid MA, Elburi A, Young LC, Mullen AB, Tate RJ, Ferro VA.

Mol Pharm. 2017 Jul 3;14(7):2450-2458. doi: 10.1021/acs.molpharmaceut.7b00352. Epub 2017 Jun 8.

14.

Metabolomic Profiling of the Synergistic Effects of Melittin in Combination with Cisplatin on Ovarian Cancer Cells.

Alonezi S, Tusiimire J, Wallace J, Dufton MJ, Parkinson JA, Young LC, Clements CJ, Park JK, Jeon JW, Ferro VA, Watson DG.

Metabolites. 2017 Apr 14;7(2). pii: E14. doi: 10.3390/metabo7020014.

15.

Comparison of the physical characteristics of monodisperse non-ionic surfactant vesicles (NISV) prepared using different manufacturing methods.

Obeid MA, Gebril AM, Tate RJ, Mullen AB, Ferro VA.

Int J Pharm. 2017 Apr 15;521(1-2):54-60. doi: 10.1016/j.ijpharm.2017.02.007. Epub 2017 Feb 3.

16.
17.

The effects of hydration media on the characteristics of non-ionic surfactant vesicles (NISV) prepared by microfluidics.

Obeid MA, Khadra I, Mullen AB, Tate RJ, Ferro VA.

Int J Pharm. 2017 Jan 10;516(1-2):52-60. doi: 10.1016/j.ijpharm.2016.11.015. Epub 2016 Nov 9.

18.

Metabolomic Profiling of the Effects of Melittin on Cisplatin Resistant and Cisplatin Sensitive Ovarian Cancer Cells Using Mass Spectrometry and Biolog Microarray Technology.

Alonezi S, Tusiimire J, Wallace J, Dufton MJ, Parkinson JA, Young LC, Clements CJ, Park JK, Jeon JW, Ferro VA, Watson DG.

Metabolites. 2016 Oct 13;6(4). pii: E35.

19.

Chemical and Antimicrobial Profiling of Propolis from Different Regions within Libya.

Siheri W, Zhang T, Ebiloma GU, Biddau M, Woods N, Hussain MY, Clements CJ, Fearnley J, Ebel RE, Paget T, Muller S, Carter KC, Ferro VA, De Koning HP, Watson DG.

PLoS One. 2016 May 19;11(5):e0155355. doi: 10.1371/journal.pone.0155355. eCollection 2016.

20.

Effect of Bee Venom and Its Fractions on the Release of Pro-Inflammatory Cytokines in PMA-Differentiated U937 Cells Co-Stimulated with LPS.

Tusiimire J, Wallace J, Woods N, Dufton MJ, Parkinson JA, Abbott G, Clements CJ, Young L, Park JK, Jeon JW, Ferro VA, Watson DG.

Vaccines (Basel). 2016 Apr 19;4(2). pii: E11. doi: 10.3390/vaccines4020011.

21.

Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines.

Savelkoul HF, Ferro VA, Strioga MM, Schijns VE.

Vaccines (Basel). 2015 Mar 5;3(1):148-71. doi: 10.3390/vaccines3010148. Review.

22.

Determination of the potential bioavailability of plant microRNAs using a simulated human digestion process.

Philip A, Ferro VA, Tate RJ.

Mol Nutr Food Res. 2015 Oct;59(10):1962-72. doi: 10.1002/mnfr.201500137. Epub 2015 Aug 12.

23.

Fertility control in wildlife: review of current status, including novel and future technologies.

Garside D, Gebril A, Alsaadi M, Ferro VA.

Adv Exp Med Biol. 2014;753:467-88. doi: 10.1007/978-1-4939-0820-2_18. Review.

PMID:
25091920
24.

Bacterial outer membrane vesicles and vaccine applications.

Acevedo R, Fernández S, Zayas C, Acosta A, Sarmiento ME, Ferro VA, Rosenqvist E, Campa C, Cardoso D, Garcia L, Perez JL.

Front Immunol. 2014 Mar 24;5:121. doi: 10.3389/fimmu.2014.00121. eCollection 2014. Review.

25.

Phytochemical and antitrypanosomal investigation of the fractions and compounds isolated from Artemisia elegantissima.

Mamoon-Ur-Rashid, Ali S, Alamzeb M, Igoli J, Clements C, Shah SQ, Ferro VA, Gray AI, Khan MR.

Pharm Biol. 2014 Aug;52(8):983-7. doi: 10.3109/13880209.2013.874534. Epub 2014 Mar 6.

PMID:
24597622
26.

Assessment of the antigen-specific antibody response induced by mucosal administration of a GnRH conjugate entrapped in lipid nanoparticles.

Gebril AM, Lamprou DA, Alsaadi MM, Stimson WH, Mullen AB, Ferro VA.

Nanomedicine. 2014 Jul;10(5):971-9. doi: 10.1016/j.nano.2013.12.005. Epub 2013 Dec 27.

PMID:
24374362
27.

The Inhibitory Effect of Haloxylon salicornicum on Contraction of the Mouse Uterus.

Saleem NH, Ferro VA, Simpson AM, Igoli J, Gray AI, Drummond RM.

Evid Based Complement Alternat Med. 2013;2013:714075. doi: 10.1155/2013/714075. Epub 2013 Sep 23.

28.

Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi.

Acevedo R, Callicó A, Aranguren Y, Zayas C, Valdés Y, Pérez O, García L, Ferro VA, Pérez JL.

BMC Immunol. 2013;14 Suppl 1:S10. doi: 10.1186/1471-2172-14-S1-S10. Epub 2013 Feb 25.

29.

Methanol immersion reduces spherical aberration of water dipping lenses at long wavelengths used in multi-photon laser scanning microscopy.

Norris G, Gebril A, Ferro VA, McConnell G.

Biomed Opt Express. 2012 Dec 1;3(12):3314-24. doi: 10.1364/BOE.3.003314. Epub 2012 Nov 21.

30.

Optimizing efficacy of mucosal vaccines.

Gebril A, Alsaadi M, Acevedo R, Mullen AB, Ferro VA.

Expert Rev Vaccines. 2012 Sep;11(9):1139-55. doi: 10.1586/erv.12.81. Review.

PMID:
23151169
31.

Cochleates derived from Vibrio cholerae O1 proteoliposomes: the impact of structure transformation on mucosal immunisation.

Acevedo R, Pérez O, Zayas C, Pérez JL, Callicó A, Cedré B, García L, Mckee D, Mullen AB, Ferro VA.

PLoS One. 2012;7(10):e46461. doi: 10.1371/journal.pone.0046461. Epub 2012 Oct 12.

32.

Reproductive component vaccine developments for contraceptive and non-contraceptive uses.

Ferro VA, Garside DA.

Expert Opin Ther Pat. 2011 Sep;21(9):1473-82. doi: 10.1517/13543776.2011.594042. Epub 2011 Jun 15. Review.

PMID:
21675927
33.

Adjuvant strategies required for targeting mucosal tissues.

Ferro VA, Pérez O.

Methods. 2009 Dec;49(4):299-300. doi: 10.1016/j.ymeth.2009.10.002. No abstract available.

PMID:
19909900
34.

Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection.

Mann JF, Shakir E, Carter KC, Mullen AB, Alexander J, Ferro VA.

Vaccine. 2009 Jun 2;27(27):3643-9. doi: 10.1016/j.vaccine.2009.03.040. Epub 2009 Apr 5.

PMID:
19464545
35.

Translational modifications to improve vaccine efficacy in an oral influenza vaccine.

Bennett E, Mullen AB, Ferro VA.

Methods. 2009 Dec;49(4):322-7. doi: 10.1016/j.ymeth.2009.04.015. Epub 2009 May 4.

PMID:
19409998
36.

Delivery systems: a vaccine strategy for overcoming mucosal tolerance?

Mann JF, Acevedo R, Campo JD, Pérez O, Ferro VA.

Expert Rev Vaccines. 2009 Jan;8(1):103-12. doi: 10.1586/14760584.8.1.103. Review.

PMID:
19093777
37.

Phytochemicals from Flemingia vestita (Fabaceae) and Stephania glabra (Menispermeaceae) alter cGMP concentration in the cestode Raillietina echinobothrida.

Das B, Tandon V, Lyndem LM, Gray AI, Ferro VA.

Comp Biochem Physiol C Toxicol Pharmacol. 2009 Apr;149(3):397-403. doi: 10.1016/j.cbpc.2008.09.012. Epub 2008 Sep 25.

PMID:
18854226
38.

Immunisation with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes in saline suppresses rodent fertility.

Khan MA, Ogita K, Ferro VA, Kumasawa K, Tsutsui T, Kimura T.

Vaccine. 2008 Mar 4;26(10):1365-74. doi: 10.1016/j.vaccine.2007.12.052. Epub 2008 Jan 22.

PMID:
18262690
39.
40.

The inner gel component of Aloe vera suppresses bacterial-induced pro-inflammatory cytokines from human immune cells.

Habeeb F, Stables G, Bradbury F, Nong S, Cameron P, Plevin R, Ferro VA.

Methods. 2007 Aug;42(4):388-93.

PMID:
17560326
41.

Screening methods used to determine the anti-microbial properties of Aloe vera inner gel.

Habeeb F, Shakir E, Bradbury F, Cameron P, Taravati MR, Drummond AJ, Gray AI, Ferro VA.

Methods. 2007 Aug;42(4):315-20.

PMID:
17560318
42.

Natural product research: the challenges facing the modern researcher.

Ferro VA, Gray AI.

Methods. 2007 Aug;42(4):313-4. No abstract available.

PMID:
17560317
43.

Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo.

Khan MA, Ferro VA, Koyama S, Kinugasa Y, Song M, Ogita K, Tsutsui T, Murata Y, Kimura T.

Vaccine. 2007 May 4;25(18):3544-53. Epub 2007 Feb 5.

PMID:
17316929
44.

Effect of immunisation against gonadotrophin releasing hormone isoforms (mammalian GnRH-I, chicken GnRH-II and lamprey GnRH-III) on murine spermatogenesis.

Khan MA, Prevost M, Waterston MM, Harvey MJ, Ferro VA.

Vaccine. 2007 Mar 1;25(11):2051-63. Epub 2006 Nov 30.

PMID:
17240004
45.
46.

Evaluation of two GnRH-I based vaccine formulations on the testes function of entire Suffolk cross ram lambs.

Earl ER, Waterston MM, Aughey E, Harvey MJ, Matschke C, Colston A, Ferro VA.

Vaccine. 2006 Apr 12;24(16):3172-83. Epub 2006 Feb 2.

PMID:
16483697
47.

Mucosal immunisation: Successful approaches to targeting different tissues.

Ferro VA, Carter KC.

Methods. 2006 Feb;38(2):61-4. No abstract available.

PMID:
16442812
48.

Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity.

Mann JF, Scales HE, Shakir E, Alexander J, Carter KC, Mullen AB, Ferro VA.

Methods. 2006 Feb;38(2):90-5.

PMID:
16414269
49.

Translation of an experimental oral vaccine formulation into a commercial product.

Carter KC, Ferro VA, Alexander J, Mullen AB.

Methods. 2006 Feb;38(2):65-8. Review.

PMID:
16406571
50.

Efficacy of an anti-fertility vaccine based on mammalian gonadotrophin releasing hormone (GnRH-I)--a histological comparison in male animals.

Ferro VA, Khan MA, McAdam D, Colston A, Aughey E, Mullen AB, Waterston MM, Harvey MJ.

Vet Immunol Immunopathol. 2004 Sep;101(1-2):73-86.

PMID:
15261694

Supplemental Content

Loading ...
Support Center